Cars.com
CARS
Hutchmed (China)
HCM
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
US Stock MarketDetailed Quotes
OKLO Oklo Inc
- 25.800
- +2.110+8.91%
Trading Mar 11 12:01 ET
3.53BMarket Cap-57.33P/E (TTM)
26.460High23.550Low8.23MVolume23.790Open23.690Pre Close207.89MTurnover8.14%Turnover RatioLossP/E (Static)136.80MShares59.14052wk High13.40P/B2.61BFloat Cap5.35052wk Low--Dividend TTM101.15MShs Float59.140Historical High--Div YieldTTM12.28%Amplitude5.350Historical Low25.249Avg Price1Lot Size
Oklo Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q2)Jun 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Operating expense | 163.33%12.28M | 430.01%17.77M | 7.37M | 4.66M | 39.99%3.35M | 94.23%10.02M | 2.4M | 5.16M |
| Selling and administrative expenses | 144.63%7.23M | 364.03%7.05M | --3.71M | --2.96M | 55.72%1.52M | 49.04%4M | --975.92K | --2.68M |
| -General and administrative expense | 144.63%7.23M | 364.03%7.05M | --3.71M | --2.96M | 55.72%1.52M | 49.04%4M | --975.92K | --2.68M |
| Research and development costs | 195.71%5.05M | 484.70%10.72M | --3.66M | --1.71M | 29.18%1.83M | 143.18%6.02M | --1.42M | --2.48M |
| Operating profit | -163.33%-12.28M | -430.01%-17.77M | -7.37M | -4.66M | -39.99%-3.35M | -94.23%-10.02M | -2.4M | -5.16M |
| Net non-operating interest income expense | 3,130.49%2.55M | 1,252,143.80%1.72M | 141.3K | 78.84K | -19.88%137 | -81.12%920 | 171 | 4.87K |
| Non-operating interest income | 3,130.49%2.55M | 1,252,143.80%1.72M | --141.3K | --78.84K | -19.88%137 | -81.12%920 | --171 | --4.87K |
| Other net income (expense) | -1,069.96%-13.13M | -16.79M | -4.08M | -1.12M | ||||
| Gain on sale of security | ---- | -1,069.96%-13.13M | ---16.79M | ---4.08M | ---1.12M | ---- | ---- | ---- |
| Income before tax | -12.30%-9.73M | -552.14%-29.18M | -24.02M | -8.67M | -86.85%-4.47M | -94.39%-10.02M | -2.39M | -5.16M |
| Income tax | 224.96K | 163.62K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -14.90%-9.96M | -555.80%-29.35M | -24.02M | -8.67M | -86.85%-4.47M | -94.39%-10.02M | -2.39M | -5.16M |
| Net income continuous Operations | -14.90%-9.96M | -555.80%-29.35M | ---24.02M | ---8.67M | -86.85%-4.47M | -94.39%-10.02M | ---2.39M | ---5.16M |
| Minority interest income | ||||||||
| Net income attributable to the parent company | -14.90%-9.96M | -555.80%-29.35M | -24.02M | -8.67M | -86.85%-4.47M | -94.39%-10.02M | -2.39M | -5.16M |
| Preferred stock dividends | ||||||||
| Other preferred stock dividends | ||||||||
| Net income attributable to common stockholders | -14.90%-9.96M | -11,459.78%-517.28M | -24.02M | -8.67M | -86.85%-4.47M | -94.39%-10.02M | -2.39M | -5.16M |
| Basic earnings per share | -12.69%-0.08 | -14,006.41%-5.17 | -0.1967 | -0.071 | -86.85%-0.0367 | -94.39%-0.0821 | -0.0196 | -0.0422 |
| Diluted earnings per share | -12.69%-0.08 | -14,006.41%-5.17 | -0.1967 | -0.071 | -86.85%-0.0367 | -94.39%-0.0821 | -0.0196 | -0.0422 |
| Dividend per share | ||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
